journal article·2021-06-09

Plasmid DNA Nanoparticles for Nonviral Oral Gene Therapy

S. M. Shatil Shahriar, Jeong Man An, Mohammad Nazmul Hasan, Sachin S. Surwase, Yeu-Chun Kim, Dong Yun Lee, Sungpil Cho, Yong-kyu Lee

Nano Letters· Volume 21· Issue 11
Publisher page

Abstract

Herein, a bile acid-inspired triple padlock oral gene delivery platform is developed, facilitating the protection of the therapeutic gene from gastrointestinal degradation, selective intestinal accumulation through a bile acid-specific transporter, and transportation of pDNA NPs through the enterohepatic recycling system. This nonviral oral gene delivery nanoparticle exhibits excellent gene expression kinetics in in vitro, in vivo, and ex vivo studies. A single oral dose leads to maintaining normoglycemia for up to 7 days in three different diabetes mouse models and 14 days in diabetic monkeys. Also, the optimized dosage form can reduce nonfast blood glucose levels and hemoglobin A1C within a normal range from the last stage diabetes conditions with a reduction of weight gain from changes of food uptake behavior after treatment once weekly for 20 weeks. Taken together, the current findings could improve the current painful treatment experience of diabetics and thus improve their quality of life.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: RNA Interference and Gene Delivery · Advanced Drug Delivery Systems · Pancreatic function and diabetes

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Chemical and Biological Engineering, Korea National University of Transportation, Chungju-27469, Republic of Korea

KB Biomed Inc., Chungju 27469, Republic of Korea

Department of Bioengineering, College of Engineering, Hanyang University, Seoul 04763, Republic of Korea

Department of Green BioEngineering, Korea National University of Transportation, Chungju-27469, Republic of Korea

Department of Chemical & Biomolecular Engineering, Korea Advanced Institute of Science and Technology (KAIST), Daejeon-34141, Republic of Korea

Department of Bioengineering, College of Engineering, and BK21 PLUS Future Biopharmaceutical Human Resources Training and Research Team, Hanyang University, Seoul 04763, Republic of Korea

Institute of Nano Science and Technology (INST), Hanyang University, Seoul 04763, Republic of Korea

4D Biomaterials Center, Korea National University of Transportation, Jeungpyeong 27909, Republic of Korea

Funding

National Research Foundation of Korea

References (20)

Show source-provided references
1. 10.1002/advs.20170107910.1002/advs.201701079 ↗
2. 10.1177/19322968120060063010.1177/193229681200600630 ↗
3. 10.1016/j.jconrel.2017.08.03510.1016/j.jconrel.2017.08.035 ↗
4. 10.1021/acsami.0c0981410.1021/acsami.0c09814 ↗
5. 10.1021/acs.nanolett.0c0463810.1021/acs.nanolett.0c04638 ↗
6. 10.1016/j.nantod.2019.10076510.1016/j.nantod.2019.100765 ↗
7. 10.1002/adma.20160659610.1002/adma.201606596 ↗
8. 10.1021/acsami.0c2217010.1021/acsami.0c22170 ↗
9. 10.1016/j.biomaterials.2011.01.04310.1016/j.biomaterials.2011.01.043 ↗
10. 10.1038/sj.gt.330048410.1038/sj.gt.3300484 ↗
11. 10.1038/s41428-019-0232-110.1038/s41428-019-0232-1 ↗
12. 10.1093/toxsci/kfv11410.1093/toxsci/kfv114 ↗
13. 10.1038/s41586-019-1902-z10.1038/s41586-019-1902-z ↗
14. 10.2337/db06-055810.2337/db06-0558 ↗
15. 10.2337/db06-118210.2337/db06-1182 ↗
16. 10.1016/j.freeradbiomed.2010.02.02510.1016/j.freeradbiomed.2010.02.025 ↗
17. 10.1038/s41551-017-007810.1038/s41551-017-0078 ↗
18. 10.1002/dmrr.108010.1002/dmrr.1080 ↗
19. 10.3810/pgm.2014.11.283610.3810/pgm.2014.11.2836 ↗
20. 10.1016/j.addr.2007.05.01510.1016/j.addr.2007.05.015 ↗